1. Fever in pregnancy and the postpartum period

2. Revised guidelines on clinical management and laboratory investigation of patients with seasonal influenza virus infection

3. Request for issue of Oseltamivir capsules on Named Patient Basis.

4. Guidelines on malaria chemotherapy and management of patients with malaria.

5. Conducting post -mortem examinations on maternal deaths.

6. Performance of duties in the post of Inquirer (into sudden deaths).

7. Prescribing and issuing of Morphine for Cancer pain Management.

8. Guidelines on Pregnant Mothers Leaving Against Medical Advice.

9. Promotion of Branded Milk Power within Health Institutions and to the staff of the Ministry of Healthcare and Nutrition.

10. Lactation Management Centres (LMC).

11. Summary Guidelines for clinical management of patients with Ebola Virus Disease (EVD) infection.

12. Provision of EQA to private sector hospitals performing AFB microscopy.

13. Surveillance of Cancers in Sri Lanka - Obtaining Cancer incidence data through private sector pathology laboratories.

14. Surveillance of Cancers in Sri Lanka - Provision of Comprehensive Cancer Incidence Data.

15. Revised notification and Investingation System for Adverse Events Following Contraceptive Usage, Contraceptive Failures and Suspected Quality Failures of Contraceptive Commodities.

16. Guidelines on Management of Dengue Fever and Dengue Haemorrhagic Fever.

17. Influenza A&B virus infection including H1N1 in pregnancy.Management guidelines for clinicians and healthcare providers.

18. Family-Planning-Services-In-Curative-Institutions-1.

19. Family-Planning-Services-In-Curative-Institutions-2.

20. Consumer Affairs Authority ACT, NS1 Antigen Test for Dengue and Full Blood Count (FBC) Test

21 stamp  Duty Act 12 of 2006

http://www.phsrc.lk/content/files/helthcirculars/Stamp%20Duty%20Act%20No%2012%20of%202006.pdf

22. Measles, Rubella, Congenital Rubella  Syndrome

   https://drive.google.com/file/d/1CH0vZC28ewSiakv6uVbZdCDgv0Mh2Ll5/view?usp=drive_link

23. Reporting of measles and other notifiable diseases by private healthcare institutions 

24. Obtaining contact details when obtaining samples at private sector laboratories and collection centres